Other research have shown that there is no correlation among BZD use and cognitive decrease. One particular analyze confirmed that administration of BZD in clients with Alzheimer’s disease never produce more cognitive decline following 18 months of taking the drug [74]. The topics During this analyze experienced delicate to moderate Alzheimer’s